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Skin lesions and 
environmental exposures
Unlike most organs, the skin is in constant contact with the external environment. The skin ensures the body’s 
integrity by preserving internal fluids and electrolytes, maintaining thermoregulation, and protecting against 
physical injury and entry of harmful agents. Because the skin has such a prominent and protective role, many 
factors affect it adversely, including mechanical agents (friction, vibration, pressure, and trauma); physical agents 
(heat, cold, and radiation); biologic agents (plants, insects, animals, and microbes); and a variety of chemical 
agents.
The large number of chemicals in the home and workplace and the accidental and intentional releases to air, 
water, and soil potentially allow ever-increasing contact with chemicals in the environment. Dermatitis from 
chemical exposures in the workplace accounts for about 30% of all reported occupational illness; the prevalence 
of skin lesions due to chemicals encountered outside the workplace (i.e., environmental exposures) may never 
be known.
Seven common skin conditions that can have environmental etiologies are presented in this monograph. Accurate 
diagnoses and identification of etiologies are necessary, not only to properly treat skin diseases, but also to 
prevent future occurrence of disease or exposure.
Familiarity with the vocabulary of dermatology is helpful in understanding this specialized topic. A glossary of 
terms begins on page 42.
(a) What are the most likely nonoccupational etiologies for four of the more common skin conditions: 
irritant and allergic contact dermatitis, urticaria, and photosensitivity?
(b) What are the most effective treatments and preventive measures for each of these skin conditions?
Answers begin on page 39.
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Skin Lesions
Case 1 —  Irritant Contact Dermatitis
A husband and wife consult you because of skin rashes that have developed since they began renovating a 
recently purchased older home. They have no history of skin problems.
The man complains o f severe itching o f the hands and an erythematous rash with papules and excoriations on 
the arms and lower legs. This rash began during the time he was placing new insulation in the attic.
The woman complains of a rash with redness and a small amount of blistering on the hands and wrists. There is 
mild itching, and some painful fissures have formed on the fingertips. The rash developed over a period of several 
days, beginning with only erythema while she was using a commercial paint-stripping product to remove old paint 
from interior trim. Although she wore rubber gloves, some of the stripping compound came in contact with her skin 
by running down into the gloves from the wrist area and through small holes in the fingers.
(la )
C fu tC k jy je -^r
What is the most likely cause of the husband's rash? How could this be confirmed?
(1b) What are the most likely causes of the woman’s rash?
(1c) How would you treat the skin lesions experienced by these patients?
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Description
More than 90% of skin lesions 
caused in the workplace are 
contact dermatitis.
Lesions of irritant contact 
dermatitis are localized and 
the symptoms are generally 
less severe than those of 
allergic contact dermatitis.
In the occupational exposure setting, the most common skin lesions 
(greater than 90%) are dermatitis due to either contact irritation or 
contact allergy, with irritant contact dermatitis being reported more 
frequently.
Irritant contact dermatitis caused by chronic exposure to mild irritants 
typically begins with erythema and progresses to eczema with exuda­
tive vesicles and papules, most often limited to the area of direct contact. 
Itching, stinging, and burning sensations may be noted— especially with 
stronger irritants—but are generally not as severe as symptoms of 
patients who have allergic contact dermatitis. (For a discussion of 
allergic contact dermatitis, see page 9.)
After days to weeks of chronic irritant exposure, the skin may become 
lichenified. Painful fissures may develop, along with hyperpigmentation, 
crusts, and scales. When contact with the offending irritant is discontin­
ued, the rash usually resolves spontaneously in 1 to 3 weeks. Irritant 
contact dermatitis rarely spreads to areas of the body remote from the 
site(s) of direct contact.
Cutaneous hardening can develop when patients with irritant contact 
dermatitis have daily exposure to irritating substances. The skin 
becomes tough and resistant at the sites of contact, allowing further 
exposure to the irritant but without reaction. If exposure ceases, 
however, this protective adaptation is lost rapidly.
Pathophysiology
Irritant contact dermatitis 
is caused by direct action 
of irritants on the skin.
Irritant substances cause dermatitis by direct chemical action (i.e., 
nonimmune-mediated) on contacted components of the skin. Irritants 
may be acidic substances, which coagulate skin proteins, or alkaline 
substances, which remove surface lipids. Both types of substances 
may cause drying and cracking of the skin. Epidermal necrosis with 
separation of the epidermis from the underlying dermis results in 
formation of vesicles that contain mainly polymorphonuclear (PMN) 
leukocytes. Vesicles and bullae with both PMN leukocytes and lympho­
cytes occur in the upper portion of the dermis.
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Common Etiologies
Almost any substance can be a contact irritant (Table 1), although 
some substances, such as some alcohols, oils, and glycols cause 
irritant contact dermatitis in only a small percentage of exposed 
persons. In contrast, strong irritants, such as concentrated mineral 
acids, alkalies, and amines, cause chemical burns or irritant contact 
dermatitis in almost everyone exposed. Mild to moderate irritants (e.g., 
dilute acids, organic hydrocarbon solvents, and some detergents) 
generally produce irritant dermatitis in only a small percentage of 
persons after a single contact but will cause a reaction in nearly 
everyone after prolonged or repeated exposure.
Table 1. Common irritants in the home and workplace*
Home
Bleaches
Copper and metal brighteners
Detergents
Drain cleaners
Fertilizers
Furniture polishes and waxes 
Oven cleaners
Pesticides
Pet shampoos
Rug shampoos
Scouring pads and powders
Soaps
Toilet bowl cleaners 
Window cleaners
Workplace
Acids and alkalies 
Cleaning products 
Epoxy resins
Foams (e.g., insulation foams) 
Noncarbon-required (NCR) paper 
Powders
Aluminum 
Calcium silicate 
Cement
Cleaning agents 
Metallic oxides
Particles
Ore particles in mining 
Plant particles 
Plastics, dry 
Sawdust 
Wool
Volatile substances 
Ammonia 
Formaldehyde 
Organic solvents
‘ Adapted from Robert M. Adams, Occupational skin disease, 2nd edition. Philadelphia: 
W.B. Saunders Co., 1990.
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Diagnosis
□  Onset of irritant contact 
dermatitis tends to be 
insidious.
Treatment
□  Removal from exposure is 
the most important step in 
treating irritant contact 
dermatitis.
The young are generally more susceptible to irritant contact dermatitis 
than adults are because the threshold for skin irritation is low in children, 
particularly infants. Irritation reactivity gradually lessens after about 
8 years of age. During play, children are likely to have skin contact with 
soils containing hazardous substances or with wooden playground 
structures that may have been treated with irritating chemicals such as 
arsenate and pentachlorophenol. The occurrence of skin problems is 
also common in the elderly. Besides age, personal factors that predis­
pose persons to irritant contact dermatitis include genetic constitution 
and previous episodes of eczema.
Environmental and physical factors influence the skin’s susceptibility to 
irritant contact dermatitis. Susceptibility is often enhanced by wet work 
and conditions such as cold and windy weather, low relative humidity, 
and high temperatures that cause sweating. Some anatomic regions 
are more sensitive than others. Friction and lacerations or other me­
chanical skin injury may facilitate the development of irritant contact 
dermatitis. Occlusion by protective equipment such as gloves provides 
a humid environment, minimizing evaporation and making the stratum 
corneum more permeable to chemical substances that come in contact 
with the skin.
Irritant contact dermatitis is often difficult to differentiate from allergic 
contact dermatitis. Routine skin biopsy generally is not helpful because 
the histologic appearance of irritant and allergic contact dermatitis is 
similar. However, unlike allergic contact dermatitis, irritant contact 
dermatitis tends to localize at the exposed area and to cause mild itching 
and more erythema than vésiculation. The onset of irritant contact 
dermatitis is insidious rather than explosive. Patch testing by, or in 
consultation with, a dermatologist may be necessary to reach a diagno­
sis or to exclude allergic contact dermatitis. If fibrous glass is the 
suspected irritant, skin scrapings suspended in a few drops of 10% 
potassium hydroxide and examined under a light microscope at low 
power may reveal glass fibers.
The most important step in treatment is to remove the patient, at least 
temporarily, from further exposure to the offending agent. Substituting 
less irritating chemicals for the offending substance and correctly 
using protective materials, such as gloves and barrier creams, may 
help reduce exposure. During healing, the skin should be protected 
from other insults such as frequent washing, trauma, wind, and rapid 
changes in temperature.
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Treatment for acute vesicular irritant contact dermatitis includes topical 
application of wet dressings for 15 to 20 minutes, 3 to 6 times daily. 
Domeboro’s solution (diluted 1:40) or Burow’s solution may be used to 
soak the dressings. Dressings should be discontinued after 2 to 3 days 
to avoid drying the skin.
Topical application of corticosteroid preparations may be efficacious. 
A low-potency corticosteroid should be used for mild to moderate skin 
conditions, with progression to more potent corticosteroids as required 
(Table 2). Some over-the-counter and prescription topical medications 
or their excipients can further irritate the skin or provoke allergic contact 
dermatitis. Administering mild sedatives and antihistamines to relieve 
itching may also be beneficial.
Clinical signs of secondary bacterial infection include increased ery­
thema and tenderness; development of a yellow, crusting, or purulent 
exudate; and occasionally, formation of small pustules around the 
edges of the dermatitis. Infection with monilia has an appearance similar 
to bacterial infection, except that the exudate is usually white. Infection 
may be difficult to recognize initially because the serous exudate and 
erythema of the dermatitis can obscure the signs. Obtaining samples of 
the exudate for culture and sensitivity before initiating topical or systemic 
antibiotic therapy is generally advisable.
□  Topical corticosteroids may 
be useful in cases of irritant 
contact dermatitis.
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Table 2. Groups of topical corticosteroid products, in order of decreasing potency*
Drug
Group 1
Betamethasone dipropionate 
Halbertasol propionate 
Clobetasol propionate 
Diflorasone diacetate
Group II
Amcinonide
Betamethasone dipropionate 
Desoximetasone 
Diflorasone diacetate 
Fluocinolone acetonide 
Fluocinonide 
Halcinonide
Triamcinolone acetonide 
Group III
Betamethasone benzoate 
Betamethasone valerate 
Desoximetasone 
Flurandrenolide 
Hydrocortisone valerate 
Triamcinolone acetonide
Group IV
Betamethasone valerate 
Clocortolone pivalate 
Fluocinolone acetonide 
Flurandrenolide 
Triamcinolone acetonide
Group V
Alclometasone dipropionate 
Desonide
Fluocinolone acetonide
Group VI
Dexamethasone 
Hydrocortisone 
Methylprednisolone acetate
Trade Namet
Diprolene
Ultravate
Temovate
Psorcon
Cyclocort
Diprosone
Topicort
Florone, Maxiflor
Synalar-HP
Lidex
Halog
Aristocort, Kenalog, etc.
Benisone, Uticort 
Betatrex, Beta-Val 
Topicort LP 
Cord ran 
Westcort
Aristocort, Kenalog, etc.
Valisone, Reduced Strength 
Cloderm
Fluonid, Flurosyn, Synalar, etc. 
Cordran SP
Aristocort, Kenalog, Triacet
Aclovate
DesOwen, Tridesilon 
Fluonid, Synalar
Aeroseb-Dex, Decaderm 
(generic, over-the-counter) 
Medrol
% Concentration
0.05
0.05
0.05
0.05
0.1
0.05
0.25
0.05
0.2
0.05
0.1
0.5
0.025
0.1
0.05
0.025
0.2
0.1
0.01
0.1
0.025
0.025
0.025
0.05
0.05
0.01
0 . 01 - 0.1
0.25-2.5
0.25-1.0
Adapted from RC Cornell and RB Stoughton. The use of topical steroids in psoriasis. Dermatol Clin 
1984;2:397-409.
* No significant difference exists among agents in a group. These products come in various forms 
(i.e., creams, gels, lotions, solutions, and ointments), although some products are not available 
in all forms.
t Use of trade names is for identification only and does not imply endorsement by the Public Health 
Service or the U.S. Department of Health and Human Services.
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Case 2  —  Allergic Contact Dermatitis
You are consulted by a 44-year-old male office worker who has a chief complaint o f a rash on his hands and wrists. 
His company recently relocated from a building where each employee had a private office to an older, renovated 
building with large bay areas. New wallboard was placed, the area was painted, and new carpet was laid just before 
the move. Employees now work in cubicles; the patient's cubicle is located in an interior area with no windows. 
A copying machine is adjacent to his work area.
Since the move, many of the patient's coworkers have been complaining of unpleasant odors, a feeling of fatigue 
or excessive tiredness, and mild irritation of the eyes, nose, and throat. They associate these symptoms with 
working in the new area. Although the patient has not noted such symptoms, he does complain o f the increased 
noise and distraction in the new work area; he feels that his rash is somehow related to the new location.
The rash began 5 days ago with itching and redness. It then developed weeping and raised, vesicular lesions that 
spr&ad from the initial location on the hands to the volar surfaces of the wrists. The patient states that he has a 
history o f reaction to poison ivy, which produces a similar rash, but he has not been in an infested area for the past 
2 months. He has no direct contact with industrial cleaning agents or carbonless copy paper in his work. He does 
have contact with chemicals through his woodworking hobby. He recently built an end table from exotic Japanese 
woods and has been applying a varnish that a friend brought from Japan.
C fu ttfe n g e -s^
(2a) Could the patient's rash be due to airborne allergens or irritants in the new office 
location?
(2b) Could the rash be related to his woodworking hobby?
(2C) What is the most effective treatment for this patient?
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Description
□  About 30% of occupational 
skin disorders are allergic 
contact dermatitis.
□  In sensitized persons, 
inflammation begins about 
12 hours after exposure to 
an allergen.
Pathophysiology
□  Cross-reactivity with 
antigenically similar 
substances can occur with 
allergic contact dermatitis.
□  The clinical and histologic 
appearances of allergic and 
irritant contact dermatitis 
are similar.
Although contact allergens produce sensitization in only a small percent­
age of exposed persons, allergic contact dermatitis constitutes about 
30% of the skin disorders found in the workplace. Once a person has 
been sensitized to an offending substance, further exposure may result 
in relatively rapid development of local inflammation with erythema, 
papule formation, induration, and weeping vésiculation. Inflammation 
usually begins about 12 hours after exposure; intensity peaks in 50 hours 
or more. The rash may spread locally around the margins of the original 
site or to distant sites that did not have contact with the allergen. 
Potentially, the entire skin surface could become involved (a condition 
known as erythroderma or exfoliative dermatitis).
Allergic contact dermatitis results from a true allergic (i.e., cell-mediated) 
sensitization to the offending substance. Cross-reactivity with antigeni­
cally similar substances may occur. Initially, during the refractory 
period, the patient may be exposed without developing a reaction. 
During the induction phase, which may last from 4 days to several weeks 
(usually about 14 to 21 days), the development of complete allergic 
sensitization occurs as the allergen comes in contact with the skin. After 
the skin is fully sensitized, further contact with the allergen may result in 
rapid and severe dermal manifestations. When no further contact with 
the allergen occurs, the patient is in the period of persistence of 
sensitivity. The level of sensitivity can decrease over time, but sensiti­
zation may be lifelong.
Most allergens that cause allergic contact dermatitis have molecular 
weights of less than 500 daltons. The allergens are haptens rather than 
complete antigens; they must penetrate the skin and combine with 
endogenous proteins to form full antigens. Langerhans cells play a key 
role in then presenting the antigen to T lymphocytes, thereby activating 
the T cells. The sensitized T cells proliferate in the paracortical regions 
of the lymph nodes and produce effector and memory lymphocytes that 
remain in the general circulation. On subsequent contact with the complete 
antigen, the effector cells release lymphokines that may result in rapid 
and severe, local inflammation.
Many factors can affect the development of allergic contact dermatitis, 
including characteristics of the allergen itself, patient factors, and 
environmental conditions. Allergen factors include the physiochemical 
nature of the allergen (e.g., lipophilicity, solubility, and inherent sensitiz­
ing potency), concentration, total dose that comes in contact with the 
skin, anatomic site of contact, number and frequency of exposures, and 
occlusion by clothing or gloves.
10
Skin Lesions
The most important predisposing patient factors are a history of irritant 
contact dermatitis and the presence of an inflammatory skin condition 
that may promote absorption of the allergen. Irritant dermatitis caused 
by household cleaning agents on women's hands may continue as 
allergic nickel dermatitis (from costume jewelry). In addition, age and 
genetic predisposition can influence the development of allergic 
contact dermatitis. Persons who have histories of atopic dermatitis have 
been reported to have decreased risk of developing allergic dermatitis 
but increased risk of developing irritant dermatitis.
Common predisposing environmental factors for allergic contact der­
matitis are pressure, friction, heat, and prolonged immersion in water 
(such as occurs during wet work). Relative humidity, ambient temperature, 
and season of the year also play roles in development of allergic contact 
dermatitis.
Only several hundred of the thousands of chemicals used are known 
to cause allergic contact dermatitis. With the exception of nickel, 
cobalt, and some forms of chromium, most metals do not produce 
sensitization. Strong inorganic alkalies and acids seldom cause 
allergic reactions. Although a substance’s sensitization potential 
cannot be determined from its chemical structure alone, some chemi­
cal classes are more likely to cause allergic contact dermatitis (see 
Table 3). Aromatic compounds with polar or ionic substituents are 
typically sensitizing agents (e.g., p-aminophenol and hydroquinone 
used in photographic film developers).
In addition, chemicals that are structurally similar to the original 
sensitizing agent may provoke recall of the specifically sensitized 
lymphocytes, a phenomenon known as cross-sensitization. For ex­
ample, persons exposed to p-phenylenediamines used in the rubber 
industry may react to related substances used in photographic 
developers and dyes. Persons sensitized to Rhus plants such as 
poison ivy or poison oak may be sensitive to cross-reacting sub­
stances found in exotic trees and their derivative products (lacquers, 
varnishes, and oils).
Table 3. Some chemical groups known to cause allergic 
contact dermatitis
Aromatic amines 
Benzothiazoles 
Caine-type anesthetics 
Ethylenediamine compounds 
Halogenated germicides
Hydroxyquinolines 
Phenolic compounds 
Phenothiazines
Streptomycin group of antibiotics 
Thiurams
Common Etiologies
Aromatic compounds with 
polar or ionic substituents are 
potent sensitizing agents.
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Synthetic substances that commonly cause allergic contact dermatitis 
are rubber products, plastic resins, organic dyes, topical medications, 
germicidal and biocidal preparations, and various commercial and 
medication ingredients (Table 4). Natural products can also produce 
allergic contact dermatitis. Exposure to certain airborne contaminants 
may also cause allergic contact dermatitis. Airborne contaminants 
include dichromates in cement dust, rosins used in soldering operations, 
and sawdust.
Table 4. Common causes of allergic contact dermatitis
Germicides and biocides Metals
Formaldehyde-releasing compounds Chromium
Parabens Cobalt
Quaternary ammonium compounds Nickel
Grains Organic dyes
Barley p-Aminoazobenzene
Oat p-Phenylenediamine
Rye
Wheat Plastic resins
Epoxies
Foods/Spices Formaldehyde-based acrylics
Cardamon Lettuce Phenolics
Carrot Potato
Chicory Radish Rhus plants*
Coconut Tamarind Poison ivy
Coffee Tumeric Poison oak
Endive Vanilla Poison sumac
Medication/product ingredients Rubber products
Preservatives Antioxidants
Lanolin Polymerization accelerators
Thimerosal
Fragrances and perfumes Topical medications
Balsam of Peru Benzocaine
Benzyl alcohol Neomycin
Cinnamic acid derivatives
Citronella derivatives
* For a more complete listing of plants that cause dermatitis see R.M. Adams, Occupational 
skin disease, 2nd edition, Philadelphia: W .B. Saunders Co., 1990, p. 507-9.
Diagnosis
Allergic contact dermatitis 
often spreads to areas remote 
from the site of contact.
Allergic contact dermatitis is often misdiagnosed as irritant contact 
dermatitis. Other conditions to consider in the differential diagnosis are 
atopic dermatitis, pustular eruptions on the palms and soles, psoriasis, 
Herpes simplex and Herpes zoster, insect bites, parasite infestation 
such as scabies, fungal infections of the feet with idiopathic vesicular 
reactions, nummular eczema, drug eruptions, and erythema multiforme.
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No distinctive features of the lesions facilitate the differentiation of 
allergic from irritant contact dermatitis. An important diagnostic clue to 
allergic contact dermatitis is the spread of rash to areas remote from the 
site of contact; the mucous membranes are usually spared, and the 
scalp, soles, and palms are often unaffected.
Patch testing (see Diagnostic Procedures, page 35) may help differen­
tiate allergic from irritant contact dermatitis. Because the histologic 
appearance of lesions due to allergic or irritant contact dermatitis is the 
same, routine skin biopsy is not helpful in their differentiation.
At present, there are no satisfactory means of desensitizing humans to 
allergens. The most important step is to remove the patient from 
exposure to the offending substance. In the workplace, options such as 
protective clothing and substitute chemicals should be explored. The 
therapy for allergic contact dermatitis is the same as that for irritant 
contact dermatitis (see Treatment, Irritant Contact Dermatitis, page 6).
Systemic corticosteroids may be indicated for some patients who have 
allergic contact dermatitis, especially when large areas of the skin (20% 
total body surface area or greater) are involved. Short courses of oral 
corticosteroids, particularly if used for a Rhus-induced contact derma­
titis, may be given for 2 to 3 weeks (up to 21 days). Corticosteroids 
administered even for a short period of time should always be delivered 
in decreasing doses over the course of therapy to prevent adrenal 
suppression.
□  The clinical and microscopic 
appearances of skin lesions 
due to allergic contact dermatitis 
are the same as those due to 
irritant contact dermatitis.
Treatment
□  Treatment for allergic contact 
dermatitis is identical to that 
for irritant contact dermatitis.
13
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Case 3 —  Photosensitivity Contact Dermatitis
You are consulted by the headmaster of a children's summer camp because of an outbreak of skin rashes in 20 
of the campers. No counselors are affected. On examination, the rashes, which are confined to the hands, wrists, 
and forearms, consist of discrete linear streaks and patches that are hyperpigmented and do not itch.
One of the staff members speculates that the rashes are caused by contact with an epoxy glue used in building 
a model. However, only two of the children who have rashes have been involved in this activity. All the affected 
children had participated in a craft class in which they made lime sachets by puncturing lime skins and inserting 
sprigs of cloves over the surfaces of the limes. During the class, they also prepared gift cards from recycled paper. 
W hite the children attended to these activities, the counselors were engaged in planning an outdoor activity that 
was to follow the craft session.
(3a) What causes of the children's dermatitis might be considered, given the rural location and nature 
of camp activities?
(3b) What treatment would you recommend?
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Description
Photosensitivity contact dermatitis occurs mainly on sun-exposed areas 
such as the face, upper chest, posterior portion of the neck, extensor 
surfaces of the forearms, dorsum of the hands and feet, and anterior 
surfaces of the lower legs. Areas of the skin normally covered by jewelry 
and clothing are spared, as are eyelids, areas under the chin, and upper 
portions of the ears covered by hair. Photosensitivity contact dermatitis 
may be the result of phototoxicity or photoallergy.
Lesions of phototoxic and photoallergic contact dermatitis resemble 
those of irritant and allergic contact dermatitis. They have been de­
scribed as discrete, confluent, polymorphous linear streaks and patches 
that are macular and nonpruritic. The patient may experience a stinging 
or burning sensation of the skin, typically beginning shortly after expo­
sure to sunlight and resolving rapidly when the skin is shaded. Lichéni­
fication and hyperpigmentation may occur, and the lesions may persist 
for months or years. In some cases, widespread involvement of the skin 
develops later. The photoallergic response usually occurs in only a 
small number of persons who have been previously sensitized to the 
photoactive agent.
Pathophysiology________________________________________________________
The mechanisms of photosensitivity contact dermatitis are broadly 
analogous to the mechanisms of irritant and allergic contact dermatitis 
except for the added requirement of appropriate ultraviolet (UV) radia­
tion (i.e., wavelengths of 315 to 400 nanometers, known as UV-A). The 
agent that provokes the irritant or allergic response is formed after its 
precursor has been exposed to UV-A.
In phototoxicity, the excited state of the agent produced during irradia­
tion is thought to lead to oxidation of cellular components or to allow 
binding of the agent with nucleic acids. In photoallergy, the initial 
reaction of the topical agent with UV-A forms either an excited molecule 
that can bind with protein to form a complete allergen or a product that 
is itself a strong contact allergen.
Common Etiologies_____________________________________________________
Many products that cause photosensitivity dermatitis are applied topi­
cally. Common examples are lotions containing fragrances; suntanning 
products with ultraviolet absorbers such as 6-methylcoumarin, 
homosalicylate, or p-aminobenzoic acid (PABA); and aftershave lotions 
containing musk ambrette. Germicides in soaps and detergents may 
also cause photosensitivity dermatitis. A major epidemic of allergic 
contact dermatitis occurred in Great Britain in 1960 afterthe introduction 
of two soaps that contained tetrachlorosalicylanilide, a photoactive 
antibacterial agent.
□  Many topical products can 
produce photosensitivity 
dermatitis.
□  Sunlight can cause
formation of the agents that 
result in photosensitivity 
contact dermatitis.
□  Photosensitivity reactions 
occur mainly on sun-exposed 
areas of the body.
□  Photoallergic reactions are 
immune-mediated responses; 
phototoxic reactions are not.
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Certain systemically administered medications have caused photoaller- 
gic drug reactions. Examples include nalidixic acid, phenothiazines, 
sulfonamides, sulfonylureas, tetracyclines, and thiazide diuretics. Phar­
macists, nurses, and others who routinely have skin contact with these 
drugs are prone to photosensitivity dermatitis.
Plants such as celery and citrus fruits have caused phototoxic dermatitis 
in persons who handle them extensively; farm workers are particularly 
susceptible. Contact with oil released from lime skins or with coal tar and 
pitch has resulted in phototoxic dermatitis, especially in lightly pig­
mented persons.
Psoralens, which are photoactive and can cause phototoxic dermatitis, 
are also used therapeutically in the treatment of psoriasis. In PUVA 
(psoralen plus UV-A radiation) treatment, a psoralen is painted on the 
affected skin or given systemically to patients who are then exposed 
to UV radiation. The photoadduct that is formed between the psoralen 
and DNA serves to slow the rate of the psoriatic overgrowth.
Photoallergy from chemical contact must be differentiated from 
polymorphous light eruption, systemic lupus erythematosus, pellagra, 
dermatomyositis, porphyria, allergic contact dermatitis and photoallergic 
drug reaction. A thorough history of medication treatment will usually 
rule out photoallergic drug reaction.
Photopatch testing may be useful in confirming the diagnosis, but 
results of photopatch testing are often difficult to interpret and are best 
left to dermatologists with specialized equipment and knowledge in this 
field.
The treatment for phototoxic or photoallergic dermatitis is the same as 
the treatment for irritant and allergic contact dermatitis (see pages 6 and 
13). Identifying the offending agent and counseling the patient to avoid 
further exposure to it are the most important interventions. When the 
photosensitizing agent cannot be avoided, limiting sunlight exposure 
and wearing protective clothing, such as hats, gloves, long-sleeved 
garments, socks, and shoes, may help. Sunscreens may be used if 
reaction or cross-sensitivity between the causative agent and compo­
nents in the sunscreen is not a possibility.
□  Psoralens, which can cause 
phototoxic dermatitis, are 
useful in the treatment of 
psoriasis.
Diagnosis
□  A thorough drug history will 
usually rule out photoallergic 
drug reactions.
Treatment
□  Treatment for phototoxic and 
photoallergic dermatitis is the 
same as that for irritant 
and allergic contact dermatitis.
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Case 4  —  Chloracne
A 42-year-old man consults you because of a persistent skin condition that he feels resembles the cosmetically 
displeasing acne he had as a teenager. His present skin condition consists of pale yellowish, cystic lesions and 
comedones localized on the face, below and lateral to the eyes, and behind the ears. Similar lesions are present 
on the cheeks, forehead, and neck; a few are present on the buttocks, where, according to the patient, he never 
had lesions with his prior affliction. He also complains of moderately severe itching.
History reveals no changes in diet, and the patient is not taking medications. For the last 15 years, the patient has 
worked for a local utility company. His most recent job duties have included replacing the heat exchange fluids 
in transformers. He first noted the rash about a month ago; he is not certain whether the rash appeared before 
or after he began this activity.
(4a) Is the skin condition described by the patient consistent with a reactivation of acne vulgaris? 
What other causes should be considered?
(4b) What therapy would you recommend?
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Description
Environmental acne is a variety of acne venenata typically caused by 
industrial chemicals. It may result from contact with petroleum and its 
derivatives (oil acne), coal tar products (coa-tar-pitch acne), and halo- 
genated aromatic hydrocarbons (chloracne). Environmental acne may 
also be caused by certain physical, mechanical, and biologic agents. 
Although the occurrence of chloracne is rare (probably fewerthan 4000 
cases worldwide), it is of great concern because it is an extremely 
refractory acne and because it may be indicative of systemic toxicity by 
a highly toxic chemical.
The lesions of chloracne consist of straw-colored cysts, numerous 
comedones, milia, and papules. The lesions are located on the face 
(especially at “crow’s feet” and below and to the outside of the eyes 
[malar crescent]), neck, earlobes, shoulders, abdomen, legs, buttocks, 
and genitalia. The nose is often spared. With severe chloracne, all the 
follicles in an area may be involved, resulting in a rather bizarre 
“pebbled” appearance. Pruritus is common and occurs in about 50% of 
chloracne cases.
□  Chloracne is often
refractory to treatment.
Common Etiologies
□  Chlorinated aromatic Many chlorinated aromatic hydrocarbon compounds used in the work-
hydrocarbons cause place can cause chloracne. These compounds include chlorinated
chloracne. naphthalenes, polychlorinated biphenyls (PCBs), polybrominated bi­
phenyls (PBBs), dioxins, polychlorinated dibenzofurans, pentachloro- 
phenol, azobenzenes, and azoxybenzenes. (See Case Studies in 
Environmental Medicine: Polychlorinated Biphenyl (PCB) Toxicity, Case 
Studies in Environmental Medicine: Dioxin Toxicity, and Case Studiies 
in Environmental Medicine: Pentachlorophenol Toxicity.)
Onset of disease is typically delayed 2 to 4 weeks after exposure to a 
chloracnegenic agent. The first changes are a thickening of the follicular 
epithelium, development of comedones, and a slow disappearance of 
the sebaceous glands as they are replaced by keratinous cysts. Initially, 
inflammation is uncommon; inflammatory lesions with larger cysts and 
abscesses are later developments. Severe scarring may occur. In­
creased fragility of the skin, hypertrichosis, widespread follicular 
hyperkeratosis, or hyperpigmentation may develop. A brownish discol­
oration of the nails, swollen eyelids, and conjunctivitis or discharge may 
be present in some patients.
With no additional exposure, the disease will first progress, then regress 
over a 4- to 6-month period. A few cases of chloracne have persisted for 
30 years or more after contact with the chloracnegenic agent has 
ceased.
Chloracne is rare and is 
usually due to occupational 
exposure to chloracnegenic 
agents.
Chloracne may be an 
indication of systemic 
toxicity.
Pathophysiology
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Chloracne must be differentiated from oil acne or folliculitis due to 
exposure to grease and oils; acne vulgaris; acne cosmetica from heavy 
cosmetic use; acne mechanica from local pressure and friction; acne 
medicamentosa from medications such as corticosteroids, hormonal 
preparations, phenytoin, iodides (e.g., in kelp tablets), bromides and 
solar elastosis with comedones.
A history of exposure to agents known to cause chloracne and the typical 
appearance of the rash on physical examination are usually sufficient for 
diagnosis. Chloracne may be distinguished from acne vulgaris by the 
distribution of the lesions, age at onset, and morphology. Chloracne 
lesions typically affect the face, neck, earlobes, shoulders, abdomen, 
legs, buttocks, and genitalia, whereas lesions of acne vulgaris are found 
primarily on the face, neck, chest, and back (down to the waist). 
Chloracne can appear at any age, whereas acne vulgaris is seen most 
often in patients aged 13 to 26 years. Chloracne lesions consist of straw- 
colored cysts, numerous comedones, milia, and papules; whereas the 
lesions of acne vulgaris are typically comedones, papules, pustules, 
and scars.
Histologic examination of cysts may show typical changes, but the 
usefulness of biopsy in establishing the diagnosis is questionable. 
Associated noncutaneous conditions found in some patients who have 
chloracne include hepatotoxicity, porphyria cutanea tarda, and periph­
eral neuropathies.
Diagnosis
□  Chloracne must be
differentiated from other 
more common acnes.
Treatment
Primary interventions are prevention of exposure to chloracnegenic 
chemicals and good hygiene because a satisfactory treatment regimen 
cannot be found in many cases. Administration of oral antibiotics and 
acne surgery have been of limited success. Retinoic acid (vitamin A) 
preparations or 13-cis-isoretinoic acid (Accutane) have been successful 
in carefully selected patients. (Note: Accutane is a known teratogen and 
should be used cautiously.) Injecting inflamed lesions with dilute 
triamcinolone, a glucocorticoid, may be helpful, as may dermabrasion 
for severe scarring.
Removal from exposure to 
chloracnegenic agents is the 
most important treatment for 
chloracne.
21
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Case 5  —  Pigment Alterations
Fifteen children from a local school are referred by the school nurse for evaluation o f skin lesions. The lesions 
consist of decreased pigmentation in a scattered distribution. Two of the children have histories of itchy, weeping, 
vesicular rash on the neck and face that cleared before the pigment changes became noticeable. A public health 
evaluation of the drinking water and food served at the school has not revealed toxic or infectious agents. The 
school is located near a chemical manufacturing facility, in which the parents of several children work, including 
the parents of the two children who have histories of vesicular rash.
¡ 2 ^
C ftaiC cnger-s'r
(5a) Could the nearby manufacturing facility be associated with the decreased pigmentation noted in 
the children in this case?
(5b) How could you investigate this possibility?
(5c) What treatment options are available for persistent hypopigmentation involving large areas of 
the skin?
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Description
□  Pigment changes are usually 
associated with post- 
inflammatory effects from 
physical or chemical agents.
A variety of physical and chemical agents may affect the color of the 
skin. Insults to the skin may cause either increased pigmentation 
(hyperpigmentation), decreased pigmentation (hypopigmentation), or 
both in contiguous areas (dyschromia). Inflammation, which may be 
subclinical and not apparent, usually precedes pigment alterations. 
Postinflammatory reaction (e.g., to contact dermatitis) is the most 
common cause of increased pigmentation, although pigment loss may 
also occur.
Pathophysiology
□  Hypopigmentation is caused by 
damage to the melanocyte or 
through inhibition of melanin 
synthesis.
□  Hyperpigmentation is often 
caused by nonspecific skin 
damage that leads to melanin 
or hemosiderin accumulation.
In hypopigmentation, depigmentation probably occurs either by dam­
age to the melanocyte, which leads to cell distortion and death, or 
through inhibition of melanin synthesis by the offending substance. It 
may be significant that industrial compounds that cause hypo­
pigmentation (Table 5) are structurally similar to tyrosine, the building 
block of melanin. In industrially related hypopigmentation (leukoderma), 
the hands, wrists, and forearms invariably are affected; symmetry is 
usual. Depigmentation may also appear in body sites remote from the 
chemical contact (e.g., axillae, genitalia, and torso). The process of 
depigmentation usually takes 2 to 4 weeks and may require up to 6 
months of repeated contact to become visible. The fact that many 
exposed workers do not lose pigment indicates that host factors are 
important in susceptibility.
Table 5. Compounds known to cause hypopigmentation
o-Benzylchlorophenol (antiseptic)
p-Butylphenol (used in the manufacture of varnish and lacquer resins, as 
an antioxidant in soaps, and as a motor oil additive) 
p-Cresol (disinfectant)
Hydroquinone and its monoethyl and monobenzyl ethers (used in black- 
and-white photoprocessing, in skin lighteners, and as antioxidants 
in synthetic rubbers) 
o-Phenylphenol (used as an agricultural fungicide, disinfectant, and in 
the rubber industry)
Pyrocatechol (topical antiseptic) 
p-Tertiary butylcatechol (astringent)
Hyperpigmentation (also known also as melanosis or melanoderma) is 
due to accumulation of melanin from damaged melanocytes or to 
deposition of hemosiderin from extravasation of erythrocytes in the 
dermis. Another possible mechanism is overproduction of melanin by 
melanocytes in response to the offending agent. Hyperpigmentation is 
more likely to occur in dark-complexioned persons and can persist for years.
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Common Etiologies
The cause of hypopigmentation is contact with alkylphenols (see 
Table 5, page 24), skin damage due to chemical and thermal burns, 
or blunt or repeated trauma to the skin. Hyperpigmentation typically 
follows a bout of dermatitis or other episode of inflammation. Coal 
tar pitch, creosote, and various aromatic chlorinated hydrocarbons 
are a few of the compounds that can stimulate overproduction of 
melanin. UV radiation-induced stimulation of melanin synthesis 
(tanning) is the most common cause of hyperpigmentation 
in dark-complexioned persons.
Diagnosis
Chemically induced hypopigmentation is indistinguishable from idio- □  
pathic vitiligo. Vitiligo affects about 1% of the general population and 
may be associated with autoimmune or endocrine abnormalities. 
Hypopigmentation must also be differentiated from depigmentation 
due to tissue destruction by chemical or thermal burns.
Hyperpigmentation should not be confused with birthmarks or direct 
skin staining or discoloration from contact with substances such as 
heavy metals (e.g., silver salts), nitrosylated compounds (e.g., nitric acid 
or dinitrophenol), derivatives of coal distillation (e.g., tar, pitch, and 
asphalt), and coal dust.
In most cases, the patient’s history and physical examination are 
sufficient to diagnose cases of pigment alterations. The loss of melanin 
in light-complexioned persons can be detected by failure of the skin to 
fluoresce under a Wood’s lamp.
Treatment
□  Hypopigmented and 
hyperpigmented areas 
should be protected from 
sunlight.
In patients who have hyperpigmentation, worsening of the condition 
can be prevented by using sunscreens and covering affected areas
No effective treatment exists to reverse pigment changes. Hypo­
pigmentation may last months to years after contact with the offending 
substance is discontinued, or it may be permanent. Depigmented skin 
should be protected from sunlight. Small depigmented areas may be 
camouflaged with agents such as Covermask, Dy-O-Derm, or 
Dermablend. Oral administration of psoralens and carefully graded UV 
radiation exposure (PUVA treatment) may be attempted if hypo­
pigmentation involves large areas of skin.
Hypopigmentation may be the 
result of environmental 
exposures or of idiopathic 
vitiligo.
Skin staining and birthmarks 
can be misdiagnosed as 
hyperpigmentation.
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with clothing, hats, and gloves. Topical bleaching creams prepared 
from hydroquinone or its monobenzyl ether must be used cautiously 
to prevent widespread depigmentation. A preparation consisting of
0.1% hydrophilic tretinoin (Retin-A), 5% hydroquinone, and 0.1% 
dexamethasone in a hydrophilic ointment has been used in a 5- to 7- 
week treatment regimen with some success.
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1. Acute irritant contact dermatitis—Exposure to a strong 
irritant, ethylene oxide, produced this markedly swollen arm 
and an acute vesiculo-bullous dermatitis. A similar pattern 
may be seen with contact allergy.
2. Subacute irritant contact dermatitis—This patient 
developed a bilateral and symmetric subacute dermatitis from 
the rubber accelerator, mercaptobenzothiazole, which was 
leached from the rubber portion of his work shoe due to 
sweating. Some edema and erythema with an eczematous erup­
tion can be noted.
3. Chronic irritant contact dermatitis—The hands, wrists, 
and forearms are the most frequent sites of involvement in cases 
of industrial contact dermatitis. The hands and wrists of this 
worker show the effect of long-term exposure to a solvent, 
kerosene, which he used to clean his skin. The skin is markedly 
thickened, hyperpigmented, dry, and fissured. Itching is usu­
ally a major symptom.
4. Fibrous glass contact dermatitis—Contact with fibrous 
glass, particularly large-fiber diameter, can produce itching; 
lesions may not be visible except for secondary effects from 
scratching or rubbing. In some persons, small erythematous 
papules may occur where the spicules have penetrated, as 
shown here.
5. Allergic contact derm atitis—This severe allergic contact 
dermatitis was due to a phenol-formaldehyde resin. These 
resins are used as bonding agents for foundry sand, in elec­
trical devices, and in molded and cast plastic articles. The 
resins also can produce irritant reactions.
6. Poison ivy contact dermatitis—The Rhus genus of plants 
includes poison ivy, poison oak, and poison sumac. Poison 
ivy dermatitis may be acquired from direct contact with the 
plant o r from the smoke of burning poison ivy plants.
• #
7. Photosensitivity contact dermatitis—Many chemicals need 
light to activate and produce the complete phototoxin or 
photoallergen. Psoralens in limes produced this vesicular 
phototoxic dermatitis in a bartender who squeezed limes all 
afternoon in direct sun.
10. Hypopigmentation—The hands o f this hospital mainte­
nance worker are depigmented from contact with a phenolic 
germicidal detergent. Irritation or sensitization to the chemical 
is not a prerequisite for pigment loss. The loss o f pigment may 
be permanent.
8. Chloracne—Chloracne is a refractory type of acne caused 
by certain halogenated aromatic chemicals; it can be accom­
panied by systemic toxicity. Chloracne in this herbicide pro­
duction worker involved almost every follicular orifice on his 
face and neck, producing comedones, papules, and cystlike 
lesions.
11. Contact urticaria—Contact urticaria is an unusual 
urticarial or w heal-and-flare response occurring upon exter­
nal contact with certain agents. This is the clinical presenta­
tion of a worker sensitive to ground meat. The reaction 
developed within 30 minutes. Some cases of contact urticaria 
involve immunologic mechanisms; others do not. Itching may 
be the only manifestation.
m
9. Acne vulgaris—Acne-prone workers who have contact with 
oils frequently have poral occlusion problems. Hot, humid 
environments may cause sufficient hydration and swelling to 
predispose the skin to acne. This worker’s head was positioned 
in such a way as to constantly crease one side of his neck, 
causing recurrent deep lesions in that one location.
12. Skin neoplasms—Skin cancer is the most common form 
of cancer. Skin tumors, such as this ulcerating squamous cell 
carcinoma, most frequently arise after years o f occupational 
exposure, or they are common complications from long-term 
exposure to solar radiation.
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Case 6  —  Contact Urticaria
A 35-year-old woman consults you because of episodes of generalized hives that develop about 20 minutes after 
she uses certain brands of shampoo. The hives are preceded by sensations of itching, burning, and stinging of 
the skin on the scalp, upper face, and posterior aspect of the neck. The patient also experiences redness and 
tearing of the eyes, clear rhinorrhea, and nausea. She relates that a similar constellation of symptoms occurred 
after she applied an over-the-counter topical pain-relieving ointment for sunburn. A mild eczematous rash has 
been present on her forehead and posterior neck for about 6 weeks.
Cñüttengi
(6a) What is the most likely cause of the patient's complaints?
(6b) What evaluation and testing might be helpful?
(6c) What treatment will most likely be effective?
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Description
Contact urticaria is a localized wheal-and-flare response (hives) that 
develops almost immediately (a few minutes to about 1 hour) after direct 
contact with the eliciting agent. Many afflicted patients complain of skin 
sensations such as itching, burning, or tingling. Symptoms typically 
disappear within 24 hours.
□  Contact urticaria is a skin 
reaction that appears 
immediately after contact 
with the offending agent.
Pathophysiology
□  Contact urticaria may 
be due to immunologic-, 
nonimmunologic-, or 
uncertain-mediated 
mechanisms.
□  Anaphylactic reactions 
may occur in patients who 
have contact urticaria 
syndrome.
Contact urticaria may be mediated by mechanisms classified as immu­
nologic (allergic), nonimmunologic (nonallergic), or uncertain. 
Nonimmunologic urticaria, the most common type of contact urticaria, 
is caused by a direct action of the offending substance on the skin 
vasculature and a nonimmunologic release of vasoactive substances 
such as bradykinin, histamines, or other inflammatory mediators. The 
reaction remains localized.
Immunologic contact urticaria is an immediate allergic reaction in 
persons who have previously become sensitized to the offending 
agent. Parts of the skin that are remote from the contact site may be 
affected. The vasoactive effects in the immunologic form of contact 
urticaria are caused by an IgE-mediated reaction. The resulting ery­
thema and edema are elicited mainly by histamines released from 
mast cells. Activation of the complement cascade and generation of 
anaphylatoxins can result in systemic effects (contact urticaria syn­
drome) in which the typical rash is accompanied by symptoms of 
asthma, rhinitis, conjunctivitis, orolaryngeal effects (itching and tin­
gling sensations or edema of the lips, tongue, and mouth; or throat 
irritation), or gastrointestinal signs and symptoms. In rare cases, 
patients who have contact urticaria syndrome have experienced 
otherwise unexplained attacks of vascular collapse (anaphylactoid 
reactions).
The cause of the third type of contact urticaria is uncertain but includes 
both allergic and nonallergic mechanisms. Formaldehyde is an ex­
ample of an urticant that has features of both types.
Common Etiologies
Latex rubber gloves are 
a common cause of 
immunologic contact 
urticaria.
Immunologic contact urticaria is usually caused by proteins or protein 
complexes. It may also be caused by a wide variety of common 
chemicals, medications, cosmetics, and other agents (Table 6). The 
rubber in latex gloves is a common cause of contact urticaria among 
healthcare professionals, as is the cornstarch used in the gloves. Food-
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stuffs are also a common cause of contact urticaria. The orolaryngeal 
area is a site where immediate reactions are provoked by food allergens, 
most often among atopic persons.
Table 6. Some substances that cause allergic contact urticaria
Animal products Foods Plant products
dander eggs henna
hair flour latex rubber
saliva fruits & vegetables papain
serum meats strawberries
milk woods
Common Chemicals nuts
ammonia seafood Textiles
alcohol spices silk
parabens wool
polyethylene glycol Medications
bacitracin Miscellaneous
Cosmetics cephalosporins acrylic monom
hair products chloramphenicol epoxy resin
nail polish gentamicin formaldehyde
perfumes neomycin nylon
salicylic acid seminal fluid
Nonimmunologic contact urticaria has been provoked by contact with 
substances as diverse as acids (acetic, benzoic, butyric, cinnamic, 
sorbic), alcohols (ethyl and butyl), balsam of Peru, benzocaine, cin­
namic aldehyde, cobalt chloride, dimethylsulfoxide, formaldehyde, witch 
hazel, sodium benzoate, and esters of nicotinic acid. Cold temperatures 
can also cause nonimmunologic contact urticaria.
Uncertain mechanism-mediated contact urticaria has been associated 
with exposure to ammonium persulfate, which is used to boost peroxide 
hair bleaches to achieve a platinum-blond effect. Sunlight, which can 
produce rapid development of a wheal-and-flare reaction in exposed 
areas, and aquagenic agents (water, saline, or the patient’s own 
perspiration) are also associated with uncertain mechanism-mediated 
contact urticaria.
Nonimmunologic contact urticaria must be differentiated from allergic 
contact urticaria and otherforms of urticaria. The most important factor 
in making the correct diagnosis is taking a careful history of the 
relationship between possible exposures and development of symp­
toms. In cases of chronic urticaria, a clear cause is seldom identified.
Patch or scratch/prick tests may be used with suspected etiologic 
agents. These tests should be used initially on normal areas of skin,
Diagnosis
□  A clear cause is seldom 
identified in cases of 
chronic contact urticaria.
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Treatment
□  Antihistamines can alleviate 
symptoms of urticaria.
then on involved skin (previously or currently affected) only when no 
reaction occurs on normal skin. Testing should be done by, or in 
consultation with, a dermatologist; resuscitation equipment and medi­
cations should be available in case a severe anaphylactoid reaction 
results.
Chlorpheniramine-like antihistamines are of value in treating urticaria. 
The newer agents that have less sedative effects, such as terfenadine 
(Seldane) and astemizole (Hismanal), are not as efficacious. (Note: 
Seldane and Hismanal are contraindicated in patients who are taking 
ketoconazole, itraconazole, erythromycin, or other medications known 
to impair the metabolism of Seldane or Hismanal, and in patients who 
have significant hepatic dysfunction.)
Nonsteroidal anti-inflammatory medications have proved useful in cer­
tain cases of nonimmune urticaria; however, they may cause anaphy­
laxis in patients who have immune urticaria, especially patients who 
exhibit the triad of asthma, nasal polyps, and rhinitis. These patients 
should be cautioned about the use of nonsteroidal an ti­
inflammatory agents. All patients suffering from urticaria should be 
advised to avoid further contact with the eliciting substance.
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Case 7  —  Malignant Neoplasms
A couple in their 60s who are native to a nearby rural area consult you because of the insidious development of 
a variety o f skin lesions over the past 2 years. Both have hyperkeratotic lesions on the palms and the soles of the 
feet, as well as mottled-appearing hyperpigmented areas on the temples and neck. The man has a lesion on the 
right cheek that appears to be a basal cell carcinoma. Both patients complain of numbness and tingling in the feet 
and a general feeling of fatigue.
(7a) Assuming that a single agent is responsible for the constellation of complaints of the couple, what 
sources should be investigated?
(7b) What treatment would you recommend?
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Description
Cancer of the skin is the most common neoplasm among adults in the 
United States. More than 500,000 new cases of nonmelanoma skin 
cancer and about 28,000 cases of melanoma occur annually. Skin 
cancers associated with environmental factors include basal cell carci­
noma, squamous cell carcinoma, malignant melanoma, and Bowen’s 
disease (intraepidermal squamous cell carcinoma). Pre-nonmelanoma 
skin cancers, such as actinic keratoses, can also be induced by envi­
ronmental factors.
Sunlight, either alone or in conjunction with other agents, plays an 
important role in the development of most skin cancers, especially 
malignant melanoma. The incidence of melanoma has increased more 
than 700% in the past 60 years. If the incidence continues to increase at 
the present rate, within the next decade a person’s lifetime risk of 
developing melanoma will be approximately 1% (i.e., 1 case of mela­
noma per 100 persons). The reasons for this increased risk have not 
been well established but may be related to ozone depletion in the upper 
atmosphere; increased recreational sun exposure, especially early in 
life; increased use of industrial chemicals; and increased air pollution.
The usual wavelength in sunlight that causes skin cancers is 280 to 
315 nanometers (UV-B). This range is capable of producing direct 
photochemical damage to the skin (e.g., alterations in DNA and other 
cellular constituents). UV-B also reacts with photoactive exogenous 
chemicals in or on the skin, causing them to absorb UV radiation and 
initiate or accelerate an adverse reaction in normal tissue. Industrial 
contaminants and air pollutants often contain photoactive chemicals, 
which can act as photosensitizers, additive carcinogens, or promotors.
The first association between occupational or environmental chemi­
cals and malignancy was noted in 1775 by Percival Pott who reported 
a high incidence of scrotal cancer among London’s chimney sweeps. 
Years later, it was discovered that the cancers were caused by 
exposure to certain polynuclear aromatic hydrocarbons (PAHs). PAHs 
are found in soot, pitch, creosote, petroleum, and oils such as cutting oil, 
mineral oil, and shale oil. (See Case Studies in Environmental Medicine: 
Polynuclear Aromatic Hydrocarbon [PAH] Toxicity.) Other chemicals 
found to be associated with skin tumors include phenolic compounds, 
aliphatic hydrocarbons, and inorganic arsenic compounds.
Inorganic arsenic compounds are known to cause a variety of skin 
lesions, including malignant neoplasms. Initial dermal manifestations 
of arsenic exposure may be mild erythema and hyperhidrosis of the 
palms and soles, followed by development of slightly raised, firm, 
generally symmetrical punctate keratoses. White-colored, nonraised 
hyper-keratoses may also develop on the ankles, shins, and dorsum of 
the hands. A diffuse hyperpigmentation of the skin interspersed with 
white, somewhat atrophic macules (“raindrops on a dusty road”
□  Skin cancer is the most 
common neoplasm in adults 
in the United States.
□  Sunlight, either alone or in 
conjunction with other agents, 
is a major contributing factor 
to skin cancer.
□  Reasons for the 700% 
increase in malignant 
melanoma in the past 
60 years have not been 
well established.
□  PAHs and inorganic arsenic 
are well-known causes of 
cancerous skin lesions.
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appearance) may also be seen. Basal cell and squamous cell carcino­
mas may then develop. (See Case Studies in Environmental Medicine:
Arsenic Toxicity.)
Bowen’s disease, a squamous cell carcinoma, may arise spontane­
ously in situ or may develop after chronic exposure to inorganic arsenic 
or other chemicals. Bowen’s disease consists of randomly distributed, 
sharply demarcated, erythematous, scaling lesions that range in size 
from a few millimeters up to 1 to 2 centimeters in diameter. The lesions 
grow slowly and rarely metastasize.
_______________________________________________________ Pathophysiology
Many chemical substances associated with malignant neoplasia are 
thought to interact directly with cellular macromolecules, resulting in 
neoplastic transformation of the affected cell. In some cases, absorbed 
chemicals are converted by skin enzymes (specifically, aryl hydrocar­
bon hydroxylases) to forms that then combine with DNA and other 
cellular constituents. Arsenic is thought to inhibit the enzymes involved 
in DNA replication and repair.
□  The latency period for 
development of cancerous 
lesions can be 20 years or 
more.
Some chemical agents act either concomitantly (cocarcinogens) or 
serially (promoters) to cause neoplastic transformation. In many cases, 
precancerous lesions, such as actinic or arsenical keratoses and tar 
warts, may precede the development of frank cancerous lesions. A 
latency period of several decades may lapse between exposure to a 
carcinogen and appearance of a cancerous lesion.
Common Etiologies
Certain chemical agents, such as PAHs and inorganic arsenic, are □  Sunlight is the most important 
known to cause skin cancer. Nonchemical agents that may cause cause of malignant melanoma,
malignant neoplasms include sunlight, ionizing radiation, and physical 
trauma. Sunlight is the most important cause of malignant melanoma.
Diagnosis
All potentially cancerous skin lesions must be differentiated from 
benign lesions. Suspected malignant skin lesions are diagnosed most 
accurately by histologic examination of excisional biopsies. A punch 
biopsy of suspect lesions may also be performed.
□  Diagnosis of a malignant skin 
lesion requires a biopsy.
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Treatment
□  Treatment of skin cancer 
depends on whether the 
cancer is localized or is 
metastasizing.
Prevention is the first line of defense for skin cancer. Avoiding overex­
posure to sunlight is most important. Protection from UV radiation can 
be accomplished by wearing tightly woven clothing and wide-brimmed 
hats and by applying sunscreens as absorbers. Sunscreens, which 
contain p-aminobenzoic acid (PABA) derivatives to absorb UV rays, can 
provide sun-protective factors (SPFs) ranging from 2 to 50 or more. An 
SPF of 15 allows most persons to remain out of doors for 5 hours before 
developing minimal erythema. Light-complexioned persons, persons of 
Celtic origin (i.e., Scotch, Irish, Welsh), and those with certain conditions 
(e.g., albinism, xeroderma pigmentosum, and erythropoietic proto­
porphyria) appear to be at increased risk for developing skin cancer. 
These sensitive populations may require more potent sunscreens.
Surgical excision and radiation are the most common treatment 
modalities for localized malignant skin lesions. All excised tissue should 
be sent for histologic examination to confirm the diagnosis and to be 
certain that an adequate margin of normal skin was removed. Surveil­
lance for the development of further skin cancers should be continued. 
The treatment of metastasizing skin cancers or lesions with extensive 
local infiltration is beyond the scope of this review. Patients who have 
malignant tumors should be referred to, or treated in consultation with, 
a physician knowledgeable in cancer therapy.
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Diagnostic Procedures
Obtaining and recording a detailed history of exposures (workplace, 
home, and environment) is essential in diagnosing skin disease. 
Besides physical examination, several special techniques may aid in 
the diagnosis of skin lesions. These include patch tests to detect 
contact allergy, skin biopsy, cultures, and microscopic scrapings of 
skin to detect yeasts, fungi, parasites, and fibrous glass. Referring 
patients to, or consulting with, a dermatologist who can perform or 
interpret dermatologic diagnostic testing, may be advisable.
Patch Testing
Patch testing is frequently used to differentiate between allergic 
contact dermatitis and other forms of dermatitis. The presence of a 
delayed hypersensitivity reaction to an offending substance can be 
determined by placing a suitably prepared, nonirritating amount of a 
sample on the skin (usually on the back) under a chamber or 
impervious bandage (patch). If an eczematous dermatitis lesion 
develops underthe patch during the 48 hours after application, allergy 
to the test substance or to an antigenically similar cross-reacting 
substance can be inferred. If no reaction is evident, the patches are 
removed, and the sites are reexamined for delayed reaction at 72 and 
96 hours after application.
Interpretation of patch testing is often difficult, and it is usually 
recommended that the testing be carried out in specialized centers or 
by consultants who routinely do patch testing. If no response is 
provoked, it does not mean unequivocally that the patient is not 
allergic. For example, if an offending or cross-reacting substance was 
not included, or was not applied in proper concentration, a false- 
negative result will occur.
Complications of patch testing include the “angry back syndrome,” in 
which the patient’s entire back becomes edematous and erythematous. 
Flare-up of previously existing eczema can also occur, especially 
when testing materials are not obtained from standard commercial 
sources. Even local response to the test substance may be extensive, 
causing patient discomfort. Patch testing itself can result in allergic 
sensitization to a substance to which the patient was not allergic 
previously, although this is a rare occurrence. Infections, scarring, and 
pigment alterations may also be complications of patch testing.
Photopatch Testing
When photosensitivity dermatitis is suspected, a combination of 
chemical patch testing and special light exposure may reveal the 
cause. Duplicate patches are used; one set is covered, and the other
□  Patch testing can help 
differentiate allergic from 
other forms of dermatitis.
□  Photopatch testing may 
help reveal the cause of 
photosensitivity dermatitis.
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□  Skin biopsy is not helpful 
in differentiating allergic 
contact dermatitis and 
irritant contact dermatitis.
□  Skin scrapings, UV-light 
examinations, cultures, 
and serologic testing are 
diagnostic tools used for 
various skin lesions.
set is exposed to a measured amount of UV radiation. There are 
several difficulties in the performance and interpretation of photopatch 
testing, and it should be performed by practitioners who have experi­
ence and the requisite special equipment.
Skin Biopsy
The appropriate skin biopsy (punch biopsy or excision of the lesion) 
usually can be performed under local anesthesia by experienced 
practitioners in an outpatient setting. Microscopic examination of the 
specimens obtained can allow differentiation between benign and 
malignant skin conditions. Irritant and allergic contact dermatitis can­
not be readily differentiated on routine skin biopsy.
Other Diagnostic Procedures
Other procedures include skin scrapings, UV-light examinations, cul­
tures, and serologic testing.
Skin scrapings can be used to look for fungal hyphae, for strands of 
fiberglass in suspected fibrous glass dermatitis, or for scabies mites 
and eggs. A Wood’s lamp, which produces UV radiation, can be used 
to examine suspected areas of hypopigmentation in light-complex- 
ioned persons. Areas deficient in melanin will not fluoresce under UV 
light, whereas areas of skin with normal melanin content will fluoresce.
Bacterial, viral, or fungal cultures may be indicated if dermal infections 
are considered in the differential diagnosis. Crusts, when present, 
should be lifted with a scalpel blade before swabbing the lesion with a 
sterile cotton-tipped applicator to obtain material for bacterial cultures. 
Fungi may be collected for culture media by gently scraping the skin 
with a sterile scalpel blade. Viral cultures from skin lesions require 
specialized laboratory facilities. Viruses can be collected for special 
media by unroofing lesions and swabbing with a sterile cotton-tipped 
applicator.
Patients who have immunologic-mediated contact urticaria may be 
evaluated by serologic testing. Protein electrophoresis and measure­
ment of circulating IgE may be useful.
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Answers to Pretest and Challenge Questions
Pretest questions are on page 1. Challenge questions begin on page 3.
Pretest
The Pretest questions (a) and (b) are answered in Challenge answers 1, 2, 3, and 6 below.
Challenge
(1a) The man in Case No. 1 has most likely developed an irritant contact dermatitis from the insulating material 
(e.g., fiberglass, rockwool). This possibility could be investigated by placing skin scrapings on a microscope 
slide with 1 to 3 drops of 10% potassium hydroxide (KOH) and examining the specimen under a light 
microscope using low power. The presence of fibrous strands would confirm the diagnosis. Dermatitis 
elicited by fibrous glass is variable and depends on individual characteristics and extent of exposure.
(1 b) The woman probably has either irritant or allergic contact dermatitis. The basic histopathologic appearance 
of these two conditions is essentially the same, and differentiating between them by appearance or routine 
skin biopsy is difficult. However, most paint-stripping products contain one or more of the following 
compounds: isopropyl alcohol, cresylic acid, methylene chloride, glacial acetic acid, aliphatic hydrocarbons, 
and aqueous ammonia, all of which tend to be irritants rather than allergens. The presence of mild rather 
than severe itching, more erythema than vésiculation, localized lesions, and insidious rather than explosive 
onset are more consistent with irritant contact dermatitis than with allergic contact dermatitis.
(1c) Both the man and the woman should be advised to avoid exposure to the offending substances, at least 
temporarily. Applying and rapidly removing adhesive or Scotch tape from the man’s affected skin may 
remove the fibers and help relieve the itching.
The contact dermatitis of both patients may be treated using Domeboro’s solution (1:40 dilution) or Burow’s 
solution. Dressings soaked with one of these solutions should be applied topically for 15 to 20 minutes, 6 times 
daily. Topical corticosteroids may be applied, starting with a steroid of low potency and progressing to more 
potent corticosteroids as needed. Mild sedatives and antihistamines may be administered to relieve itching. 
Topical or systemic antibiotic therapy may be used to combat secondary bacterial infection. Repeated 
exposure to UV radiation may be therapeutic in some cases, causing hardening or increased resistance to 
further irritation.
(2a) The rash of the patient in Case No. 2 is not likely to be due to airborne allergens or irritants in the new office 
location. Although some cases of allergic or irritant contact dermatitis can develop from exposure to airborne 
allergens or irritants, the patient’s occupational history and the location of the rash do not suggest this 
etiology. Eyelids, cheeks, nasal folds, and the neck most probably would be involved if an airborne agent 
in the workplace were responsible. The hand and wrist location suggests contact with an allergen that is 
handled.
(2b) Yes, the patient’s woodworking hobby, with recent introduction of various exotic woods and Japanese 
varnish (possibly derived from the Japanese lacquer tree), suggests a cross-sensitivity reaction to agents 
related to Rhus plants, to which he is known to be sensitized.
(2c) The patient probably has allergic contact dermatitis. Therapy would be identical to the regimen for irritant 
contact dermatitis described in (1 c) above. Attempts to desensitize sensitive persons have been unsuccess­
ful in most cases.
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(3a) Given the rural location and outdoor activities in which the children in Case No. 3 were involved, airborne 
allergic contact dermatitis to Rhus-type plant oleoresins (e.g., poison ivy, poison oak, poison sumac) or 
pollen could be the cause. However, vesiculation would be expected with allergic contact dermatitis. Patch 
testing could rule out this diagnosis.
Puncturing lime skins while making sachets during craft class could have exposed the children to psoralens, 
which are known photoirritants. Immediately after the craft class, the children engaged in outdoor sports. 
This combination of activities could lead to photosensitivity dermatitis. Because the counselors were 
involved in a staff meeting during the craft class and did not puncture the limes, only the children were 
affected.
(3b) One of the most important components in therapy for photoreactions is identification and avoidance of the 
photoactive agent. When exposure to the offending agent cannot be avoided, sunlight exposure should be 
minimized. Light exposure can be reduced by wearing protective clothing such as broad-brimmed hats, long 
sleeves, and tightly woven fabrics, or by using sunblocking agents. Symptomatic topical treatments may 
also be used.
(4a) The rash of the patient in Case No. 4 is more consistent with chloracne than with acne vulgaris. Acne vulgaris 
has a different appearance, and its distribution is typically the central face, back, and chest; it seldom affects 
the buttocks. The sebaceous glands are usually active in acne vulgaris, but chloracne gives the skin a "dry" 
appearance. Comedones are small in size and number in cases of acne vulgaris, whereas typical straw- 
colored cysts are almost pathognomonic for chloracne.
The patient’s occupation is a potentially relevant factor. A telephone call to a manager at the utility company 
reveals that old heat exchanger fluids contain PCBs, and in the process of replacing these fluids with less 
hazardous materials, the workers could have accidental contact with the material. The finding that PCBs are 
the most probable cause of the patient’s chloracne should prompt a health hazard evaluation by the 
appropriate regulatory authorities and should encourage action to prevent further exposure.
(4b) The chloracnegenic agent should be identified and exposure stopped. Chloracne is resistant to treatment 
in many cases. Medications used for acne vulgaris are ineffective for chloracne, but oral and topical 
antibiotics, acne surgery, injection of inflammed cysts with triamcinolone, and dermabrasion of scars may 
be efficacious. Topical application of retinoic acid (Vitamin A) or 13-cis-isoretinoic acid (Accutane) has been 
used on carefully selected patients with some success. In addition to treating the skin lesions, examination 
and testing should be performed to rule out hepatotoxicity, porphyria cutanea tarda, and peripheral 
neuropathy—all possible systemic effects of PCB exposure. (For further information, see Case Studies in 
Environmental Medicine: Polychlorinated Biphenyl [PCB ]  Toxicity.)
(5a) Yes, the manufacturing plant could be associated with the children’s skin lesions in Case No. 5. A similar 
outbreak among workers at a manufacturing facility and children in a neighboring school was reported in 
1985; a powdered thiadiazole was responsible in that case. Because an etiologic agent for the pigment 
changes in the children has not been found in routine testing of the water and food at the school, it would 
be advisable to consider other common sources in the neighborhood, such as the school playground. The 
nearby chemical manufacturing facility should also be investigated as a possible source, especially because 
the parents of the two children with more severe manifestations are employed at this plant. The parents 
could be carrying contamination home on their skin, clothing, and shoes. In addition, the children may be 
playing in an area with contaminated soil.
(5b) You could begin your investigation by contacting the nurse or health and safety manager at the parent’s 
workplace to determine whether a workplace agent or process is associated with the rashes of some 
workers. You could request from the manufacturer Material Safety Data Sheets (MSDSs) or other 
information about the raw materials, byproducts, chemical intermediates, and finished products used or 
produced at the plant.
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The Toxic Chemical Release Inventory (TRI), which is maintained by the U.S. Environmental Protection 
Agency (EPA) and is available to the public either online through the National Library of Medicine or on CD- 
ROM, could be used to determine the normal releases from the plant. Plant management, the local EPA, or 
the local fire department could be consulted to determine whether any accidental chemical releases have 
occurred recently at this facility. If soil contamination is suspected, soil samples from nearby playgrounds, 
school yards, or other play areas should be tested. Local or state health officials may be contacted for 
assistance.
(5c) If the lesions are persistent, large, and cosmetically displeasing, you could refer the children to a dermatologist 
for consideration of PUVA treatment. Sunscreens and protective clothing can protect areas with depigmented 
skin and prevent hypopigmentation from worsening.
(6a) The constellation of complaints of the patient in Case No. 6 is consistent with contact urticaria syndrome. 
Balsam of Peru and various alcohols (especially propyl alcohol and ethyl alcohol) in numerous consumer 
cosmetic products and benzocaine in many over-the-counter topical analgesic preparations could be 
causative agents.
(6b) Evaluation might include correlating the history of the illness with probable exposures, serologic studies of 
circulating IgE, and patch or scratch testing (performed by, or in consultation with, a dermatologist in a setting 
with resuscitation equipment in case of anaphylactoid reaction).
(6c) Usual treatment for contact urticaria includes advice to avoid suspected or known causative substances and 
administration of antihistamines. In certain patients, nonsteroidal anti-inflammatory medications have shown 
some efficacy.
(7a) Theconstellation of complaints of the couple in Case No. 7 suggests chronic arsenic poisoning. Arsenic toxicity 
from criminal activity, intentional surreptitious self-injury, occupational exposure, and environmental exposure 
should be investigated.
On questioning, the couple reveals that they have obtained drinking water from a private well for the past 
40 years and that they heat their home with a wood stove fueled with scrap wood. Analysis of the well water 
reveals arsenic at 0.62 milligrams per liter (mg/L), a concentration significantly above the EPA maximum 
contaminant level (MCL) of 0.05 mg/L. Ashes collected from the wood stove and soot from the chimney also 
contain arsenic in concentrations of several hundred parts per million; the most likely source of this 
contamination is arsenic-containing preservatives in the scrap wood.
(7b) Initial action should be taken to terminate further arsenic exposure; it will be futile to treat the skin lesions (or 
provide chelation therapy to reduce body burden) if exposure continues. An alternative source of drinking water 
should be substituted immediately, contaminated lumber should not be burned, and the home should be 
decontaminated. Advice on abatement and remediation and aid in investigating any other possible sources of 
arsenic may be obtained from the state or local health department. (For further information on arsenic and 
arsenic poisoning, see Case Studies in Environmental Medicine: Arsenic Toxicity.)
Treatment of the man’s basal cell carcinoma may involve radiation therapy or excisional biopsy, including 
a suitable margin of normal-appearing skin. All tissue removed should be submitted for histologic confirmation 
of diagnosis and to be certain the tissue borders are free of cancerous cells. The patient should be counseled 
to avoid prolonged exposure to sunlight and to use sunscreens or protective clothing whenever exposure to 
sunlight is anticipated.
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Glossary*
anaphylaxis. Commonly used to denote the immediate, transient kind of immunologic (allergic) reaction 
characterized by contraction of smooth muscle and dilation of capillaries due to release of pharmacologically 
active substances (histamine, bradykinin, serotonin, and slow-reacting substances), classically initiated by 
the combination of antigen (allergen) with mast cell-fixed, cytophilic antibody (chiefly igE).
acne mechanica. Acne caused or exacerbated by friction.
acne medicamentosa. Acne caused or exacerbated by several classes of drugs including antiepileptics, 
halogens, and steroids.
acne venenata. Acne produced by external irritants or drugs internally administered, 
acne vulgaris. Simple acne, probably caused by hormonal fluctuations.
bullae (singular bulla). Large bubble-like structures (vesicles) appearing as a circumscribed area of 
separation of the epidermis from the subepidermal structure, typically filled with serum.
chloracne. Acne-like eruptions due to prolonged contact with certain chlorinated aromatic hydrocarbon 
compounds.
chloracnegenic agents. Substances that cause chloracne.
comedones. A plug of sebaceous matter, capped with a blackened mass of epithelial debris, filling the 
pilosebaceous orifice.
dermatitis. Inflammation of the skin.
atopic d. Characterized by the distinctive phenomena of atopy, a Type I allergic reaction, specifically 
one with strong familial tendencies, caused by allergens such as pollens, foods, dander, and insect venoms, 
and associated with the Prausnitz-Küstner (IgE class) antibody.
allergic contact d. A delayed type of induced sensitivity (allergy) of the skin with varying degrees of 
erythema, edema, and vésiculation, resulting from cutaneous contact with a specific allergen.
irritant contact d. Irritation of skin caused by contact with substances that are toxic to epidermal or 
connective tissue cells; lesions are usually erythematous and papular, but can be purulent or necrotic, 
depending on the nature of the toxic material applied.
dermatomyositis. A progressive syndrome characterized by muscular weakness with a purplish erythema­
tous skin rash on the face.
eczema. Generic term for acute or chronic inflammatory conditions of the skin, typically erythematous, 
edematous, papular, vesicular, and crusting; often followed by lichénification and scaling and occasionally 
by duskiness of the erythema; often accompanied by sensations of itching and burning.
erythema. Inflammatory redness of the skin.
‘Adapted from Stedman’s Medical Dictionary, 25th edition, Baltimore: Williams and Wilkins, 1990. Modified with 
permission from Williams and Wilkins.
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erythema multiforme. An acute eruption of macules, papules, or subdermal vesicles presenting a multiform 
appearance, the characteristic lesion is typically over the dorsal aspect of the hands and forearms; its origin may 
be allergic, seasonal, or from drug sensitivity, and the eruption may be recurrent or may run a severe course 
(Stevens-Johnson syndrome), possibly ending in death.
excipient. An inert substance such as gum arabic, syrup, lanolin, or starch, that acts as a diluent or forms a 
vehicle for drug delivery.
folliculitis. An inflammatory reaction in hair follicles; the lesions may be papules or pustules, 
exfoliative dermatitis. General scaling of the skin, usually with erythema.
hapten. Incomplete or partial antigen; an antigen that is incapable, alone, of causing the production of 
antibodies.
hives. See urticaria.
hyperkeratosis. Hyperkeratinization; hypertrophy of the horny layer of the epidermis, 
hyperpigmentation. Increased pigmentation of the skin, 
hypertrichosis. Growth of hair in excess of normal, 
hypopigmentation. Decreased pigmentation of the skin.
keratosis. Any lesion on the epidermis marked by the presence of circumscribed overgrowths of the horny layer.
lichenification. Leathery induration and thickening of the skin with hyperkeratosis, due to a chronic inflamma­
tion caused by scratching or long-continued irritation.
leukoderma. An absence of pigment, partial or total, in the skin.
macular. Relating to or marked by a small, discolored patch or spot on the skin, neither elevated nor depressed 
below the skin's surface.
malar crescent. Around the cheek or cheekbones, 
melanin. Pigment that occurs in the hair, skin, or retinas, 
melanocytes. Pigment cells of the skin.
melanoderma. An abnormal darkening of the skin by deposition of excess melanin, or of metallic substances 
such as silver and iron.
melanoma. A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in 
the skin of any part of the body; in the early phases, the lesion is characterized by proliferation of cells at the 
dermal-epidermal junction, and the neoplastic cells soon invade adjacent tissue extensively. Melanomas 
frequently metastasize widely; most examples of this neoplasm occur in adults and may originate de novo or 
from a pigmented nevus or malignant lentigo.
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milia (singular milium). Sebaceous tubercle; Whitehead; a small subepidermal keratin cyst, usually multiple, 
therefore commonly referred to in the plural.
miliaria. An eruption of minute vesicles and papules due to retention of fluid at the mouths of the sweat 
follicles.
nummular. Marked by circular or oval lesions, 
papules. Small, solid elevations on the skin, 
photoallergy. Sensitization of the skin to light.
phototoxicity. The condition arising from overexposure to ultraviolet light, 
pruritis. Itching.
psoralens. Furo[3, 2-g]coumarin; a phototoxic chemical derived from fruits of the citrus family (e.g., limes).
psoriasis. A condition characterized by the eruption of circumscribed, discrete and confluent, reddish, silvery 
scaled macropapules.
Rhus. A genus of trees and shrubs (family Anacardiaceae) containing various species that are used for their 
ornamental foliage; poison ivy, poison oak, and poison sumac belong to this genus.
solar elastosis. Degenerative change in elastic tissue of the dermis due to repeated or constant exposure 
to sunlight over a period of years.
urticaria. Hives; an immediate eruption of itching wheals, which may be due to physical and chemical agents, 
foods or drugs, foci of infection, or psychic stimuli.
urticaria syndrome. Consists of the typical urticarial rash with systemic involvement, 
vésiculation. Blistering.
vitiligo. The appearance on the otherwise normal skin of loss of melanin pigment with white patches of varied 
sizes, often symmetrically distributed; the skin bordering the affected sites is usually hyperpigmented, and 
hair in the affected areas is usually white.
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Posttest and Credits
The Centers for Disease Control and Prevention (CDC) is accredited by the Accreditation Council for Continuing 
Medical Education (ACCME) to sponsor continuing medical education for physicians, and by the International 
Association for Continuing Education and Training (IACET) to sponsor continuing education units for other health 
professionals. The criterion for awarding continuing medical education (CME) credits and continuing education 
units (CEU) is a posttest score of 70% or better.
The Agency for Toxic Substances and Disease Registry, in joint sponsorship with CDC, is offering 1 hour of CME 
credit in category 1 of the Physician's Recognition Award of the American Medical Association and CEU for other 
health professionals upon completion of this monograph.
In addition, the series Case Studies in Environmental Medicine has been reviewed and is acceptable for credit 
by the following organizations:
The American Academy of Dermatology certifies that this educational activity has been recognized for 1 hour 
of AAD Category I credit and may be used toward the American Academy of Dermatology's Continuing Medical 
Education Award.
The American Academy of Family Physicians (AAFP). This program has been reviewed and is acceptable for 
1 prescribed hour by the American Academy of Family Physicians (term of approval: beginning January 1992). 
For specific information, please consult the AAFP Office of Continuing Medical Education.
The American College of Emergency Physicians (ACEP). Approved by the American College of Emergency 
Physicians for 1 hour per issue of ACEP Category I credit.
The American Osteopathic Association (AOA). AOA has approved this issue for 1 credit hour of Category 
2-B credit.
The American Association of Occupational Heath Nurses (AAOHN). AAOHN has approved this program for 1.0 contact hours. Applicant will receive the assigned code number in the award letter.
The American Board of Industrial Hygiene (ABIH). ABIH has approved this program for 0.5 certification 
maintenance (CM) point per 3 case studies. The CM approval number is 2817.
To receive continuing education credit (CME or CEU), complete the Posttest on page 46 in the manner shown in 
the sample question below. Circle all correct answers.
Which of the following is known to precipitate migraine headaches?
f fatigue alcoholc. grapefruit 
(c£)sunlight 
e. sleep
After you have finished the Posttest, please record your answers on the answer sheet on the inside back cover 
and complete the evaluation on the lower half of that page. Fold, staple, and mail the back cover to Continuing 
Education Coordinator, Agency for Toxic Substances and Disease Registry, Division of Health Education, E33, 
1600 Clifton Road, NE, Atlanta, GA 30333. Your confidential test score will be returned with an indication of where 
the correct answers can be found in the text. Validation of earned CME credit and CEU will also be forwarded to 
participants, and their names, if requested, will be placed on the mailing list to receive other issues in the Case 
Studies in Environmental Medicine series.
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POSTTEST: SKIN LESIONS
Circle all correct answers and record your answers on page 47.
1. Which of the following may help to differentiate irritant from allergic contact dermatitis?
a. Onset of allergic contact dermatitis is more explosive than onset of irritant contact dermatitis.
b. Spreading to areas not directly exposed is more common with irritant contact dermatitis.
c. Itching, stinging, or burning sensations are more pronounced with allergic contact dermatitis.
d. Vésiculation is more pronounced than erythema in irritant contact dermatitis.
e. routine skin biopsy
2. Which procedure(s) may be helpful in differentiating allergic from irritant contact dermatitis?
a. Wood's light examination
b. microscopic examination of skin scrapings in potassium hydroxide (KOH)
c. patch testing
d. skin biopsy and histologic examination
e. IgE level
3. Which of the following are potential complications of patch testing?
a. sensitization to a substance to which the patient was not previously allergic
b. the "angry back" syndrome
c. hemolytic anemia
d. aggravation of preexisting dermatitis
e. pigmentation changes
4. Which of the following statements are true regarding photosensitivity contact dermatitis?
a. Treatment may include graded exposure to ultraviolet radiation for "desensitization."
b. The skin lesions may resemble those of allergic contact dermatitis.
c. Photopatch testing may be useful in evaluating the condition.
d. Skin biopsy is of questionable diagnostic value.
e. Histologic examination can readily differentiate it from allergic contact dermatitis.
5. Which of the following statements are true regarding chloracne?
a. The pathophysiology of chloracne involves replacement of atrophied sebaceous glands with 
keratin-filled cysts.
b. Chloracne develops only in persons aged 13 to 26 years.
c. Skin biopsy may be useful in evaluating the condition.
d. Chloracne may develop after long-term exposure to methyl alcohol.
e. Chloracne cannot be distinguished from acne vulgaris.
6. Which of the following statements are true regarding development of dermal hypopigmentation?
a. It may develop after serious diseases such as sepsis or myocardial infarction.
b. Catecholic and phenolic compounds are chemicals usually associated with its development.
c. Idiopathic vitiligo may resemble hypopigmentation caused by chemical exposure.
d. Its mechanism may be either damage to the melanocyte or inhibition of melanin synthesis.
e. Hypopigmentation, once developed, is always a permanent condition.
7. Which of the following statements are true regarding contact urticaria?
a. The onset of hives is typically delayed for hours.
b. The only known triggering mechanism in contact urticaria is inhalation of airborne allergens.
c. Hives develop only at the site of actual contact with the offending substance.
d. Its mechanism may be mediated only by a nonimmunologic reaction.
e. Patch tests are of no use in determining the causative agent.
8. Malignant neoplasms of the skin are known to be caused by
a. combination of neomycin and visible light
b. inorganic arsenical compounds
c. ultraviolet light
d. polynuclear aromatic hydrocarbons (PAHs)
e. dioxins
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CASE STUDIES IN ENVIRONMENTAL MEDICINE: 
SKIN LESIONS and ENVIRONMENTAL EXPOSURES
If you wish CME credits or CEU, please indicate your answers to the Posttest questions on page 46 by circling 
the letters below for the correct answers. Complete the evaluation questionnaire and fill in the information 
requested on the reverse side. Tear off this page, fold, staple, and mail to Continuing Education Coordinator, 
Agency for Toxic Substances and Disease Registry, Division of Health Education, E 33 ,1600 Clifton Road, NE, 
Atlanta, GA 30333.
1. a b c d e
2. a b c d e
3. a b c d e
4. a b c d e
5. a b c d e
6. a b c d e
7. a b c d e
8. a b c d e
Evaluation Questionnaire
Please complete the following evaluation by putting a check in the appropriate box.
1. As a result of completing this monograph, I will be able to:
Describe the factors contributing to skin lesions.
Identify skin lesions that may be caused by environmental 
or occupational exposures.
List sources of information on skin lesions.
2. I am more likely to ask questions about possible 
environmental exposures as a result of reading this issue.
3. I will recommend this issue to my colleagues.
4. I will keep this issue as a reference.
Comments:_____________________________________________
YES NO UNDECIDED
□ □ □
□ □ □
□ □ □
a  a  a
□  □  □
□ □ □
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To obtain credit, please provide the information requested below.
Name
Address
Check one:
□  CM E-AM A
□  CEU
Specialty _
□  CME-AAFP
I I Contact
Hours-AAOHN
Zip
□  CME-ACEP
□  CM-ABIH
□  CME-AOA
□  CME-AAD
To be placed on mailing list, check here. □
fold here first
PLEASE
PLACE
STAMP
HERE
Continuing Education Coordinator
Agency for Toxic Substances and Disease Registry 
Division of Health Education, E33 
1600 Clifton Road, NE 
Atlanta, GA 30333
fold here second
Please send me the following Case Studies in Environmental Medicine:
□ Arsenic □ Gasoline □ Stoddard Solvent
□ Asbestos □ Jet Fuels □ Tetrachloroethylene
□ Benzene □ Lead □ 1,1,1-Trichloroethane
□ Beryllium □ Mercury □ Trichloroethylene
□ Cadmium □ Methanol □ Toluene
□ Carbon Tetrachloride □ Methylene Chloride □ Vinyl Chloride
□ Chlordane □ Nitrates/Nitrites □ Exposure History
□ Cholinesterase Inhibitors □ Pentachlorophenol □ Multiple Chemical Sensitivity
□ Chromium □ Polyaromatic Hydrocarbons (PAHs) □ Risk Communication
□  Cyanide
□  Dioxins
□  Ethylene/Propylene Glycols
□
□
□
Polychlorinated Biphenyls (PCBs)
Radiation
Radon
□
□
Reproductive and 
Developmental Hazards
Skin Lesions
staple or tape
Skin Lesions
The Agency for Toxic Substances and Disease Registry gratefully acknowledges the 
contribution of the American Academy of Dermatology in the review of this case study.
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Skin lesions and 
environmental exposures
The state of knowledge regarding the treatment of patients potentially 
exposed to hazardous substances in the environment is constantly evolving 
and is often uncertain. In this monograph, the Agency for Toxic Substances 
and Disease Registry (ATSDR) has made diligent effort to ensure the accuracy 
and currency of the information presented but makes no claim that the 
document comprehensively addresses all possible situations related to this 
topic. This monograph is intended as an additional resource for physicians 
and other health professionals in assessing the condition and managing the 
treatment of patients potentially exposed to hazardous substances. It is not, 
however, a substitute for the professional judgment of a health care provider 
and must be interpreted in conjunction with other sources of authority and in 
light of specific patient information available to such a professional.
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